News from the FDA/CDC
News from the FDA/CDC
Latest CDC data: Opioid deaths still rising
The U.S. death rate from synthetic opioids, including fentanyl, soared by 72.2% from 2014 to 2015, according to the CDC.
News from the FDA/CDC
FDA bans powdered gloves
The FDA has banned powdered gloves for use in health care settings, citing “numerous risks to patients and health care workers.”
News from the FDA/CDC
FDA warning: General anesthetics may damage young brains
FDA warning says repeated or lengthy use of general anesthetic or sedation drugs under age 3 years or in late pregnancy may affect children’s...
News from the FDA/CDC
FDA gives nod to crisaborole for atopic dermatitis
The FDA has approved crisaborole topical ointment, 2%, to treat mild to moderate atopic dermatitis in patients 2 years of age and older.
News from the FDA/CDC
XR version of Synjardy gets FDA’s nod
The extended-release version of empagliflozin coupled with metformin in a once-daily tablet has received FDA approval for use in glucose control...
News from the FDA/CDC
FDA affirms bladder cancer warning with diabetes drug
The FDA reaffirmed its warning on the possible risk of bladder cancer associated with use of the type 2 diabetes drug pioglitazone.
News from the FDA/CDC
New Zika cases in pregnant women continue to drop
There were 136 new cases of pregnant women with laboratory evidence of Zika infection reported during the 2-week period ending Nov. 30, along with...
News from the FDA/CDC
Empagliflozin first antidiabetes drug to gain cardioprotective indication
Empagliflozin is the first antidiabetes medication to be approved for reducing the risk of cardiovascular death in patients with type 2 diabetes...
News from the FDA/CDC
FDA approves vaginal insert to treat dyspareunia in menopause
It’s the first FDA-approved product containing the active ingredient prasterone, known also as DHEA. It will be marketed by Endoceutics Inc., a...
News from the FDA/CDC
Fewer Zika-infected pregnancies reported for second week in a row
The number of new Zika cases in pregnant women dropped for the second week in a row, according to data from the Centers for Disease Control and...
News from the FDA/CDC
FDA approves tenofovir alafenamide for patients with chronic hepatitis B and liver disease
FDA has approved tenofovir alafenamide (marketed as Vemlidy by Gilead Sciences) for the treatment of adults with chronic hepatitis B virus...